SCHEMBL8624693

SCHEMBL8624693

CCOP(=O)(OCC)C(C/C=C/c1ccc(Oc2ccccc2)cc1)S(=O)(=O)O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 6/20 0.40
POLB P06746 1/20 0.39
NPC1 O15118 2/20 0.39
ALDH1A1 P00352 2/20 0.39
RAB9A P51151 2/20 0.39
MEN1 O00255 1/20 0.39
LMNA P02545 1/20 0.39
KMT2A Q03164 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
TLR4 O00206 1/20 0.39
TLR2 O60603 1/20 0.39
HTT P42858 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
SRD5A2 P31213 1/20 0.36
EED O75530 1/20 0.36
PPARG P37231 2/20 0.36
RELA Q04206 1/20 0.36
NR1I2 O75469 1/20 0.36
MMP9 P14780 2/20 0.36
MMP1 P03956 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8624698 1.00 PTPN1 (0.40) PTPN1POLBNPC1ALDH1A1RAB9A
SCHEMBL8619953 0.88 PTPN1 (0.38) PTPN1ALDH1A1LMNAHTTSMN1; SMN2
SCHEMBL8619951 0.88 PTPN1 (0.38) PTPN1ALDH1A1LMNAHTTSMN1; SMN2
SCHEMBL8947181 0.86 EED (0.40) POLBALDH1A1MEN1LMNAKMT2A
SCHEMBL8622272 0.86 EED (0.40) POLBALDH1A1MEN1LMNAKMT2A
SCHEMBL8624891 0.84 EED (0.39) POLBALDH1A1MEN1LMNAKMT2A
SCHEMBL8624889 0.84 EED (0.39) POLBALDH1A1MEN1LMNAKMT2A
SCHEMBL8623258 0.83 EED (0.38) POLBEEDPPARGNR1I2
SCHEMBL8623263 0.83 EED (0.38) POLBEEDPPARGNR1I2
SCHEMBL8624984 0.79 EED (0.40) POLBALDH1A1LMNAHTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5712396-A PHOSPHONOSULFONATE COMPOUNDS USED FOR INHIBITING CHOLESTEROL BIOSYNTHESIS AND ATHEROSCLEROSIS MAGNIN DAVID R (US) 1998-01-27 US disclosed
US-5567841-A ANTICHOLESTEROL AGENT BRISTOL-MYERS SQUIBB COMPANY (US) 1996-10-22 US disclosed
US-5470845-A Methods of using α-phosphonosulfonate squalene synthetase inhibitors including the treatment of atherosclerosis and hypercholesterolemia BRISTOL-MYERS SQUIBB COMPANY (US) 1995-11-28 US disclosed